Standard Historical Cash Flow
| LAB Stock | USD 1.82 0.11 6.43% |
Analysis of Standard Biotools cash flow over time is an excellent tool to project Standard Biotools future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 653.6 K or Depreciation of 10.1 M as it is a great indicator of Standard Biotools ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Standard Biotools latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Standard Biotools is a good buy for the upcoming year.
Standard |
About Standard Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Standard balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Standard's non-liquid assets can be easily converted into cash.
Standard Biotools Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Standard Biotools to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Standard Biotools operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Standard Biotools' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Standard Biotools current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.At present, Standard Biotools' Change In Working Capital is projected to decrease significantly based on the last few years of reporting. The current year's Capital Expenditures is expected to grow to about 4.7 M, whereas Sale Purchase Of Stock is projected to grow to (5.1 M).
| 2010 | 2023 | 2024 (projected) | Change Receivables | 1.1M | 956.7K | 850.4K | Dividends Paid | 1.5M | 269.1K | 255.6K |
Standard Biotools cash flow statement Correlations
Click cells to compare fundamentals
Standard Biotools Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Standard Biotools cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (629K) | (459K) | (1.8M) | (563K) | (5.4M) | (5.1M) | |
| Change To Inventory | (2.7M) | (8.6M) | (4.8M) | (8.5M) | (4.9M) | (4.7M) | |
| Change In Cash | (71.7M) | 45.8M | (40.1M) | 52.9M | (29.8M) | (28.3M) | |
| Stock Based Compensation | 11.4M | 14.5M | 16.1M | 14.9M | 13.1M | 9.9M | |
| Free Cash Flow | (37.7M) | (28.1M) | (57.3M) | (93.2M) | (46.1M) | (48.4M) | |
| Change In Working Capital | (13.2M) | 2.4M | (19.9M) | (15.5M) | 1.8M | 1.9M | |
| Begin Period Cash Flow | 95.4M | 23.7M | 69.5M | 29.5M | 82.3M | 41.6M | |
| Other Cashflows From Financing Activities | 54.6M | 631K | 8.3M | 213.2M | 688K | 653.6K | |
| Depreciation | 15.8M | 15.9M | 15.6M | 15.0M | 15.2M | 10.1M | |
| Other Non Cash Items | 3.1M | 4.6M | 3.4M | 86.3M | 1.3M | 1.2M | |
| Capital Expenditures | 2.5M | 12.7M | 13.3M | 3.8M | 2.8M | 4.7M | |
| Total Cash From Operating Activities | (35.2M) | (15.4M) | (44.1M) | (89.4M) | (43.3M) | (45.5M) | |
| Change To Account Receivables | (2.1M) | (7.6M) | 6.7M | 1.1M | (3.0M) | (2.8M) | |
| Net Income | (64.8M) | (53.0M) | (59.2M) | (190.1M) | (74.7M) | (78.4M) | |
| Total Cash From Financing Activities | 2.8M | 20.9M | 16.0M | 230.8M | (6.8M) | (6.5M) | |
| End Period Cash Flow | 23.7M | 69.5M | 29.5M | 82.3M | 52.5M | 43.6M | |
| Total Cashflows From Investing Activities | (39.3M) | 40.0M | (11.9M) | (88.1M) | (79.3M) | (75.3M) | |
| Investments | (36.8M) | 36.8M | (11.9M) | (88.1M) | 73.6M | 77.3M | |
| Change To Operating Activities | (11.4M) | 13.2M | (20.0M) | (1.8M) | (1.6M) | (1.7M) | |
| Change To Netincome | 25.4M | 16.7M | 18.4M | 30.7M | 35.3M | 22.8M | |
| Change To Liabilities | 2.9M | 5.5M | (1.9M) | (8.8M) | (7.9M) | (7.5M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.558 | Quarterly Revenue Growth (0.14) | Return On Assets (0.15) | Return On Equity (0.37) |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.